IGRA is preferred for testing persons from groups that historically have poor rates of return for TST reading • IGRA is preferred for testing persons who have received BCG (as a vaccine or for cancer therapy) • TST is preferred for testing children younger than 5 years of age • IGRAs may be used in place of TST (without preference) to test recent contacts of persons with infectious tuberculosis with special considerations for follow-up testing - Negative results prior to 8 wks typically should be confirmed by repeating the test 8–10 weeks after the end of exposure - Repeating same test minimizes misclassification due to test discordance • IGRAs may be used in place of TST (without preference) for periodic screening to address occupational exposure to TB with special considerations regarding conversions and reversions
CST Price at posting:
$3.02 Sentiment: Hold Disclosure: Held